No.

Compound name

Structure

Pharmacological effect results

Pa Pi activity

1

N-(β-D-xylopyranosil)-thiosemicarbazide

6 of 464 Possible Pharmacological Effects at Pa > 0.500

0.654 0.007 Antimycobacterial

0.637 0.037 Antineoplastic

0.593 0.005 Antidiabetic symptomatic

0.576 0.004 Antineoplastic (small cell lung cancer)

0.548 0.005 Restenosis treatment

0.523 0.010 Antituberculosic

2

N-(β-D-galactopyranosil)-thiosemicarbazide

14 of 464 Possible Pharmacological Effects at Pa > 0.500

0.799 0.004 Antimycobacterial

0.718 0.004 Antituberculosic

0.700 0.004 Restenosis treatment

0.679 0.007 Antiviral (Influenza)

0.685 0.029 Antineoplastic

0.628 0.013 Antiviral (Poxvirus)

0.586 0.005 Antidiabetic symptomatic

0.543 0.005 Antiviral

0.564 0.028 Immunostimulant

0.549 0.014 DNA synthesis inhibitor

0.539 0.005 Antioxidant

0.544 0.013 Antibacterial

0.511 0.024 Cytostatic

0.508 0.022 Antidiabetic